Roberts Zachary's most recent trade in Allogene Therapeutics Inc was a trade of 476,190 Stock Option (Right to buy) done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | Zachary Roberts | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 476,190 | 476,190 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Zachary Roberts | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 134,530 | 134,530 | - | - | Restricted Stock Unit | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 718,763 | 718,763 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 203,307 | 203,307 | - | - | Restricted Stock Unit | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 02 Feb 2026 | 35,700 | 581,166 (0%) | 0% | 1.8 | 63,189 | Common Stock |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 21 Jan 2026 | 26,269 | 616,866 (0%) | 0% | 1.6 | 40,980 | Common Stock |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 03 Feb 2025 | 18,832 | 643,135 (0%) | 0% | 1.7 | 32,014 | Common Stock |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 614,844 | 614,844 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 173,913 | 661,967 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Sale of securities on an exchange or to another person at price $ 1.78 per share. | 21 Jan 2025 | 27,199 | 488,054 (0%) | 0% | 1.8 | 48,414 | Common Stock |
| Allogene Therapeutics Inc | Roberts Zachary | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 494,949 | 494,949 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Roberts Zachary | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 140,000 | 515,253 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Roberts Zachary | EVP of R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.17 per share. | 22 Jan 2024 | 24,690 | 375,253 (0%) | 0% | 3.2 | 78,376 | Common Stock |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2023 | 148,035 | 399,943 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 873,015 | 873,015 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Zachary Roberts | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 251,908 | 251,908 (0%) | 0% | 0 | Common Stock | |
| Instil Bio Inc | Zachary Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 245,000 | 245,000 | - | - | Employee Stock Option (right to buy) | |
| Instil Bio Inc | Zachary Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 120,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Instil Bio Inc | Zachary Roberts | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 120,000 | 120,000 | - | - | Employee Stock Option (right to buy) |